Is that clear?

The pharmaceutical cost transparency law recently enacted in Vermont and similar bills pending in other states are part of a loosely coordinated effort to pressure Congress to impose drug price controls.

The bills reflect a political consensus that drug prices and price increases are unreasonable, are limiting access by individual patients and are threatening the financial stability of the healthcare system. ...